Skip to content
Search

Latest Stories

PDA raises concern over calls for 'locum blacklist'

The Pharmacists’ Defence Association (PDA) has raised concerns over “a prominent pharmacist’s call to create a sector 'blacklist' for locums regarding disputes over rates.”

A few contractors took it to the Twitter to share screenshots of the messages by locums demanding more pay, which led to the call for ‘blacklisting’ those locums.


“The motivation regarding the current talk of creating a blacklist seems intrinsically tied to hourly rates. Although there are occasional and isolated anecdotal reports on social media of alleged incidents of locums seeking higher rates than already agreed, these are far outstripped by reports of pharmacy businesses unwilling to negotiate and who do not want to pay the necessary rate to engage a locum and instead have set capped or fixed rates,” said the PDA.

It added that all parties should honour agreements they enter into, including a pharmacy’s commitment to the NHS that it will open at set times to provide pharmaceutical services to patients and the public.

The organization reiterated that it will request an investigation by the Competition and Markets Authority if there was evidence to support a finding that two or more pharmacy businesses had colluded together to set a maximum rate they will pay locums. The PDA has revealed that it has got feedback from locums that some 'unrelated pharmacy businesses' in the same area all have the same capped maximum locum rate.

PDA also explained that a “blacklist” requires creating and maintaining a record containing individuals’ data. “The list owner must consider that everyone responsible for using personal data must follow strict rules called ‘data protection principles.”

“It is unclear how those businesses having discussions about creating a blacklist believe the above rules and rights would be met. This includes how a locum would be notified of their inclusion on a list and the reasons that justified it,” the organization noted.

The PDA also stated that the Employment Relations Act 1999 (Blacklisting) Regulations 2010 penalize the listing of trade union members for the purpose of discrimination against them. Under the regulations:

  • It is unlawful for anyone to compile, supply, sell or use a ‘prohibited list’
  • It is unlawful for an employer to refuse employment to a job applicant, to dismiss an employee, or to subject an employee to any other detriment for a reason related to a ‘prohibited list’
  • It is unlawful for an employment agency to refuse to provide its services to an individual for a reason related to a ‘prohibited list’.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less